Ignyta Raises Additional $1M Through Capital Term Loan from Silicon Valley Bank
February 28, 2013 at 09:00 AM EST
Ignyta, the personalized medicine company dedicated to improving the diagnosis and treatment of patients with rheumatoid arthritis (RA), lupus and other autoimmune diseases, announced today that Silicon Valley Bank (SVB) has expanded its support of Ignyta through an additional $1M capital term loan facility. The new facility is incremental to